---
title: "AstraZeneca initiated with an Outperform at CICC"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296709211.md"
description: "AstraZeneca initiated with an Outperform at CICC"
datetime: "2026-08-23T20:31:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296709211.md)
  - [en](https://longbridge.com/en/news/296709211.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296709211.md)
generator: "portal-rs"
---

# AstraZeneca initiated with an Outperform at CICC


### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)

## Related News & Research

- [REG - AstraZeneca PLC - AstraZeneca completes agreement for Zegfrovy](https://longbridge.com/en/news/297603898.md)
- [Key facts: LSE:AZN Zegfrovy buy; SANOVO PFS; Wan Ling Martello named](https://longbridge.com/en/news/297611733.md)
- [What Does AstraZeneca (LSE:AZN) News Mean For Its Cancer And Pipeline Growth?](https://longbridge.com/en/news/297694529.md)
- [REG - AstraZeneca PLC - Admission of Further Securities to Trading](https://longbridge.com/en/news/297665664.md)
- [AstraZeneca, Daiichi Sankyo Get New EU Approval for Breast Cancer Drug](https://longbridge.com/en/news/297613676.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**